Abstract
In order to investigate the impact of signalling proteins on the phenotype and malignant behavior of glioblastoma cells, we optimized the transfection procedure of human glioblastoma cell lines U251, U373, GaMG and of primary cells obtained from a patient's tumor using nucleofection technology in conjunction with plasmid pmaxGFP. We describe the optimization procedure, show that a high percentage of the cells can be transfected and that nucleofection does not cause phenotypic alterations of the cells. Therefore, we conclude that nucleofection is a highly efficient tool to deliver plasmids for transient protein overexpression and siRNA for specific protein knock-down to different glioblastoma cell lines or primary cells.
References
Jul 10, 1996·Human Gene Therapy·H J KimM E Bolander
Mar 14, 1998·Trends in Neurosciences·V W YongD R Edwards
Mar 31, 1998·Journal of Immunological Methods·N KruseP Rieckmann
Jun 9, 1999·International Journal of Cancer. Journal International Du Cancer·S WagnerJ C Tonn
Dec 2, 1999·Experimental Cell Research·C Hagemann, U R Rapp
May 29, 2002·Pathology International·Kazuki NabeshimaTetsuro Sameshima
May 29, 2002·Tissue Engineering·Astrid HammAnja K Bosserhoff
Mar 14, 2003·FEBS Letters·Petra LenzGerald M Feldman
Oct 30, 2003·Journal of Neuroscience Methods·Galina DityatevaAlexander Dityatev
Jan 23, 2004·Journal of Immunological Methods·Kerima MaashoFrancisco Borrego
Apr 15, 2004·Experimental Neurology·M Teresa Girão da CruzMaria C Pedroso de Lima
May 14, 2004·Pharmaceutical Research·Fars AlanaziD Robert Lu
Jun 23, 2004·Oncogene·Maria KarasaridesRichard Marais
Jul 21, 2004·Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society·Colman K ByrnesJohn W Harmon
Jul 28, 2004·Stem Cells·Uma LakshmipathyCatherine M Verfaillie
Dec 18, 2004·Biotechnology Letters·Peer LorenzRudolf Morgenstern
Jan 18, 2005·Journal of Neuroscience Methods·Pascal G LeclereDavid A Tonge
Citations
Dec 25, 2007·Cloning and Stem Cells·Asuka NakayamaSonshin Takao
Mar 17, 2009·Oligonucleotides·Maite Verreault, Marcel B Bally
Nov 14, 2013·Neuro-oncology·Carsten HagemannUlrike Stein
Mar 20, 2014·BMC Research Notes·Almuth Friederike KesslerCarsten Hagemann
Nov 13, 2012·BMC Biotechnology·Anne RichterAnnegret Wuensch
Aug 24, 2010·Neurochemical Research·H MuydermanN R Sims
Nov 1, 2007·Expert Opinion on Drug Discovery·Herbert Müller-HartmannTitus Kretzschmar
Jul 22, 2008·Nanomedicine : Nanotechnology, Biology, and Medicine·Daniela Reischl, Andreas Zimmer
Sep 25, 2009·Immunology·Gro F Flatekval, Mouldy Sioud
Mar 4, 2008·Experimental Dermatology·Sandra Y HanDavid Polsky
Sep 22, 2010·Journal of Cellular Physiology·Antony HsiehDavid Hsieh
May 7, 2011·DNA Repair·Pedro MendezRafael Rosell
Aug 1, 2015·PLoS Neglected Tropical Diseases·Kimbra G TurnerMiguel A Morales
May 19, 2020·Cell Cycle·Dahai ZhengXiaobing Xu